184 related articles for article (PubMed ID: 24841166)
1. Bladder cancer: bladder preservation--learning what we don't know.
Hussain M; Theodorescu D
Nat Rev Urol; 2014 Jun; 11(6):310-2. PubMed ID: 24841166
[TBL] [Abstract][Full Text] [Related]
2. Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer.
Chedgy EC; Black PC
JAMA Oncol; 2016 Jul; 2(7):855-6. PubMed ID: 27149036
[No Abstract] [Full Text] [Related]
3. Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer.
Mitin T
JAMA Oncol; 2016 Jul; 2(7):856-8. PubMed ID: 27149103
[No Abstract] [Full Text] [Related]
4. Selective organ preservation in muscle-invasive bladder cancer: review of the literature.
Khosravi-Shahi P; Cabezón-Gutiérrez L
Surg Oncol; 2012 Mar; 21(1):e17-22. PubMed ID: 22088598
[TBL] [Abstract][Full Text] [Related]
5. Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Johnson SB; Yu JB
Curr Oncol Rep; 2018 Jun; 20(9):66. PubMed ID: 29959582
[TBL] [Abstract][Full Text] [Related]
6. [New developments in the treatment of muscle-invasive bladder cancer].
Kerst JM; Pos FJ; Visser O; Horenblas S
Ned Tijdschr Geneeskd; 2008 Jan; 152(4):187-92. PubMed ID: 18320942
[TBL] [Abstract][Full Text] [Related]
7. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
8. Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
Kitamura H; Hinotsu S; Tsukamoto T; Shibata T; Mizusawa J; Kobayashi T; Miyake M; Nishiyama N; Kojima T; Nishiyama H;
Jpn J Clin Oncol; 2020 Dec; 50(12):1464-1469. PubMed ID: 32699909
[TBL] [Abstract][Full Text] [Related]
9. [Alternatives to cystectomy].
Niedworok C; Gratzke C
Urologe A; 2015 Apr; 54(4):504-9. PubMed ID: 25895563
[TBL] [Abstract][Full Text] [Related]
10. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives in muscle invasive bladder cancer.
Sternberg CN
Eur J Cancer; 2002 Mar; 38(4):460-7. PubMed ID: 11872337
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
D'Rummo KA; TenNapel MJ; Shen X
Am J Clin Oncol; 2019 Sep; 42(9):705-710. PubMed ID: 31368905
[TBL] [Abstract][Full Text] [Related]
13. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
[TBL] [Abstract][Full Text] [Related]
14. [Comprehensive therapy of bladder preservation for muscle invasive bladder cancer].
Li B; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):82-89. PubMed ID: 30154296
[TBL] [Abstract][Full Text] [Related]
15. Management of muscle-invasive bladder cancer: an update.
Ghoneim MA; Abol-Enein H
Nat Clin Pract Urol; 2008 Sep; 5(9):501-8. PubMed ID: 18769377
[TBL] [Abstract][Full Text] [Related]
16. Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.
Lee CY; Yang KL; Ko HL; Huang RY; Tsai PP; Chen MT; Lin YC; Hwang TI; Juang GD; Chi KH
Radiat Oncol; 2014 Sep; 9():213. PubMed ID: 25248470
[TBL] [Abstract][Full Text] [Related]
17. Aggressive management of elderly patients with muscle-invasive bladder cancer.
Weizer AZ; Montie JE; Lee CT
Nat Clin Pract Urol; 2006 Jul; 3(7):346-7. PubMed ID: 16835604
[No Abstract] [Full Text] [Related]
18. Bladder cancer.
Clark PE; Agarwal N; Biagioli MC; Eisenberger MA; Greenberg RE; Herr HW; Inman BA; Kuban DA; Kuzel TM; Lele SM; Michalski J; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Porter MP; Richie JP; Sexton WJ; Shipley WU; Small EJ; Spiess PE; Trump DL; Wile G; Wilson TG; Dwyer M; Ho M;
J Natl Compr Canc Netw; 2013 Apr; 11(4):446-75. PubMed ID: 23584347
[TBL] [Abstract][Full Text] [Related]
19. A balanced perspective on bladder preservation and systemic treatment in muscle-invasive bladder cancer.
Lin FX; Wang L; Xu ZP
World J Urol; 2024 May; 42(1):288. PubMed ID: 38700672
[No Abstract] [Full Text] [Related]
20. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy.
Sargos P; Baumann BC; Eapen L; Christodouleas J; Bahl A; Murthy V; Efstathiou J; Fonteyne V; Ballas L; Zaghloul M; Roubaud G; Orré M; Larré S
Cancer Treat Rev; 2018 Nov; 70():88-97. PubMed ID: 30125800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
